Skip to main content
Veterinary Medicines

RILEXINE DC 375 MG INTRAMAMMARY SUSPENSION FOR DRY COWS

Authorised
  • Cephalexin benzathine

Identifikacija zdravila

Ime zdravila:
RILEXINE DC 375 MG INTRAMAMMARY SUSPENSION FOR DRY COWS
Rilexine DC 375 mg suspensie voor intramammair gebruik voor droogstaande koeien
Učinkovina:
Ciljne živalske vrste:
  • krava
Pot uporabe:
  • Intramamarno dajanje

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    500.00
    milligram(s)
    /
    1.00
    Brizga
Farmacevtska oblika:
  • intramamarna suspenzija
Withdrawal period by route of administration:
  • Intramammary use
    • krava
      • Meat and offal
        4
        day
      • Milk
        43
        day
      • Milk
        12
        hour
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QJ51DB01
Status dovoljenja:
  • Valid
Authorised in:
  • Netherlands
Opis ovojnine:

Dodatne informacije

Entitlement type:
Imetnik dovoljenja za promet z zdravilom:
  • Virbac
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Haupt Pharma Latina S.r.l.
  • Virbac
Pristojni organ:
  • Medicines Evaluation Board
Številka dovoljenja :
  • REG NL 127944
Datum spremembe statusa dovoljenja:
Številka postopka:
  • FR/V/0438/001
Zadevne države članice:

Dokumenti

Combined File of all Documents

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
Dutch (PDF)
Objavljeno na: 4/05/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."